ESR1 and neoplasm: A series of reports42,43,44,45 indicated that factors associated with prognosis included tumor size, number of lymph node metastases, tumor type, tumor stage, histological grade, estrogen receptor and progesterone receptor status, chemotherapy, and antiestrogens.